Supplementary Tables – The clinical position of ramucirumab-containing regimens for advanced gastric cancer: a review of clinical trial data

Supplementary Table 1. Overview of targeted therapeutics approved for advanced gastric cancer Supplementary Table 2: Published real-world studies on ramucirumab-containing regimens in AGC Supplementary Table 3. Published clinical studies on ramucirumab-containing regimens in AGC in the first-line setting Supplementary Table 4. Published clinical studies on ramucirumab-containing regimens in AGC in the third-line and perioperative settings Supplementary Table 5. New and ongoing studies on ramucirumab in advanced gastric cancer (NCT and jRCT databases)补充表1：获批用于晚期胃癌（advanced gastric cancer）的靶向治疗药物概览 补充表2：已发表的针对晚期胃癌（advanced gastric cancer, AGC）中含雷莫芦单抗（ramucirumab）治疗方案的真实世界研究 补充表3：已发表的晚期胃癌中含雷莫芦单抗治疗方案的一线治疗临床研究 补充表4：已发表的晚期胃癌中含雷莫芦单抗治疗方案的三线治疗及围手术期临床研究 补充表5：晚期胃癌中雷莫芦单抗相关的新增及正在进行的研究（收录于NCT及jRCT数据库）